• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

#jjsv #johnson & johnson

  1. JJ Surgical Vision Dying or Not?

    The WORST lead ophthalmology company or NOT?? Come on......let them have it!
  2. WILL JJ SURG VISION SURVIVE?

    Will they?? They have lost so much PE biz along the NE corridor.
  3. Will JJ SURGICAL VISION SURVIVE?

    They have lost so much biz; it seems the PE groups will only deal with ALCON. Is JJSV going down?